Curebase

Curebase is a San Francisco-based digital health company founded in 2017, offering a next-generation, AI-powered eClinical platform designed to modernize and unify clinical trial operations. Its integrated suite addresses critical pain points across the trial lifecycle, from patient recruitment and consent to data collection and site management, all on a single system. As a private technology provider, it targets the growing demand for decentralized and hybrid trial models, positioning itself as a unified alternative to legacy, point-solution vendors in the clinical trial software market.

AI-native, unified eClinical platform integrating ePRO, eConsent, EDC, patient recruitment, and site management software into a single system.

Curebase competes in the fragmented eClinical solutions market against large suite vendors like Medidata (Dassault Systèmes) and Veeva, as well as numerous best-of-breed startups specializing in recruitment, EDC, or eCOA. Its differentiation is its claim of being a truly unified, AI-native platform designed for both sponsors and sites.